These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7807071)

  • 1. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder.
    Wilens TE; Biederman J; Mick E; Spencer TJ
    J Nerv Ment Dis; 1995 Jan; 183(1):48-50. PubMed ID: 7807071
    [No Abstract]   [Full Text] [Related]  

  • 2. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
    Amsterdam J; Brunswick D; Mendels J
    Am J Psychiatry; 1980 Jun; 137(6):653-62. PubMed ID: 6990798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic medication in children and the QT interval: case report and discussion.
    Alderton HR
    Can J Psychiatry; 1995 Aug; 40(6):325-9. PubMed ID: 7585402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1985 Feb; 142(2):155-62. PubMed ID: 3881999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children.
    Werry JS; Biederman J; Thisted R; Greenhill L; Ryan N
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1239-45; discussion 1245-8. PubMed ID: 7559320
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of drugs in attention deficit hyperactivity disorders].
    Guardiola A; Terra AR; Pereira KR; Rotta NT
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):594-7. PubMed ID: 9629412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
    Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication for children with attention disorders.
    Colson ER
    Pediatrics; 1997 Jun; 99(6):922-3. PubMed ID: 9190559
    [No Abstract]   [Full Text] [Related]  

  • 10. ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine.
    Johnson A; Giuffre RM; O'Malley K
    Can J Psychiatry; 1996 Mar; 41(2):102-6. PubMed ID: 8705955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case 6: a free solution.
    Shader RI; Oesterheld JR
    J Clin Psychopharmacol; 1995 Aug; 15(4):297. PubMed ID: 7593722
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug therapy in the treatment of minimal brain dysfunction.
    Saccar CL
    Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of attention deficit hyperactivity disorder: a critical review.
    Brown CS
    DICP; 1991 Nov; 25(11):1207-13. PubMed ID: 1763538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic antidepressants - third-line treatment for attention deficit hyperactivity disorder in school-aged children.
    Bell G; Efron D
    J Paediatr Child Health; 2015 Dec; 51(12):1232-4. PubMed ID: 26633610
    [No Abstract]   [Full Text] [Related]  

  • 20. Tricyclic antidepressants (TCA) may improve atomoxetine's efficacy.
    Niederhofer H
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):877. PubMed ID: 18346294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.